3 results match your criteria: "University of Tennessee Health Science Center and West Clinic[Affiliation]"
Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma.
Clin Cancer Res
December 2018
University of Arizona, Tucson, Arizona.
Purpose: The aurora A kinase inhibitor alisertib demonstrated single-agent clinical activity and preclinical synergy with vincristine/rituximab in B-cell non-Hodgkin lymphoma (B-NHL). This phase I study aimed to determine the safety and recommended phase II dose (RP2D) of alisertib in combination with rituximab ± vincristine in patients with relapsed/refractory aggressive B-NHL.
Patients And Methods: Patients with relapsed/refractory, diffuse, large, or other aggressive B-NHL received oral alisertib 50 mg b.
Robotic surgical management of endometrial cancer in octogenarians and nonagenarians: analysis of perioperative outcomes and review of the literature.
J Robot Surg
August 2010
Department of Obstetrics and Gynecology, University of Tennessee Health Science Center and West Clinic, Memphis, TN, USA.
The primary aim of this article is to report the outcomes of octogenarians and nonagenarians who have undergone robotic surgery for endometrial cancer. A multi-institutional research consortium was created to evaluate the utility of robotics for gynecologic surgery (benign and malignant). IRB approval was obtained at each institution.
View Article and Find Full Text PDFA multiinstitutional experience with robotic-assisted hysterectomy with staging for endometrial cancer.
Obstet Gynecol
August 2009
From the Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Northwestern University, Chicago, Illinois; Gynecologic Oncology, University of Tennessee, Chattanooga, Chattanooga, Tennessee; Department of Obstetrics and Gynecology, University of Wisconsin School of Medicine and Public Health, Aurora Health Center, Milwaukee, Wisconsin; and Department of Obstetrics and Gynecology, University of Tennessee Health Science Center and West Clinic, Memphis, Tennessee.
Objective: To report perioperative outcomes and learning curve characteristics from a multiinstitutional experience with robotic-assisted surgical staging for endometrial cancer.
Methods: A multiinstitutional robotic surgical consortium was created to evaluate the usefulness of robotics for gynecologic oncology surgery. An analysis of a multiinstitutional database of all patients who underwent robotic surgery for endometrial carcinoma between April 2003 and January 2009 was performed.